Antrum Biotech
Antrum Biotech is a healthcare innovations company dedicated to developing rapid diagnostic platforms for infectious diseases, with a focus on improving diagnostics for tuberculosis and other pulmonary diseases, especially in high-burden, resource-poor settings. Their mission is to translate research into impactful healthcare products and to be a significant contributor to global healthcare innovation.
Industries
Nr. of Employees
small (1-50)
Antrum Biotech
Cape Town, NA - South Africa, South Africa, Africa
Products
Rapid immuno-suspension diagnostic assay for extra-pulmonary tuberculosis
A rapid bead-based immunoassay designed to detect host- or pathogen-associated biomarkers in clinical samples to diagnose extra-pulmonary tuberculosis, including TB meningitis; intended to provide results in under two hours and to be compatible with standard laboratory infrastructure.
Rapid immuno-suspension diagnostic assay for extra-pulmonary tuberculosis
A rapid bead-based immunoassay designed to detect host- or pathogen-associated biomarkers in clinical samples to diagnose extra-pulmonary tuberculosis, including TB meningitis; intended to provide results in under two hours and to be compatible with standard laboratory infrastructure.
Services
Feasibility studies
Analysis of critical technical and market aspects to determine probability of project or product success.
Antibody isolation and modification
Tissue culture-based antibody isolation and affinity chromatography for purification and custom antibody design/modification.
Immunoassay development
R&D capability to develop novel immunoassays, with specialization in ELISA and lateral-flow formats.
Platform refinement and validation
Analytical and performance optimization to improve sensitivity, specificity and reproducibility of immunoassay platforms, including electrochemical formats.
Manufacturing and scale-up
Process development and scale-up services to transfer analytical platforms to larger-scale production.
Clinical sample processing and storage
Rapid sample processing for human clinical samples, sample management and logistics, and on-site bio-repository capabilities to support clinical studies.
Feasibility studies
Analysis of critical technical and market aspects to determine probability of project or product success.
Antibody isolation and modification
Tissue culture-based antibody isolation and affinity chromatography for purification and custom antibody design/modification.
Immunoassay development
R&D capability to develop novel immunoassays, with specialization in ELISA and lateral-flow formats.
Platform refinement and validation
Analytical and performance optimization to improve sensitivity, specificity and reproducibility of immunoassay platforms, including electrochemical formats.
Manufacturing and scale-up
Process development and scale-up services to transfer analytical platforms to larger-scale production.
Clinical sample processing and storage
Rapid sample processing for human clinical samples, sample management and logistics, and on-site bio-repository capabilities to support clinical studies.
Expertise Areas
- Rapid diagnostic development for infectious diseases
- Immunoassay design and validation
- Biomarker discovery and qualification
- Clinical sample processing and biobanking
Key Technologies
- Immunoassays (ELISA, lateral flow)
- Immuno-suspension (bead-based) assay platforms
- Electrochemical immunoassays
- Antibody purification and affinity chromatography